The selective PI3Kα inhibitor BYL719 as a novel therapeutic option for neuroendocrine tumors: Results from multiple cell line models.
about
The selective PI3Kα inhibitor BYL719 as a novel therapeutic option for neuroendocrine tumors: Results from multiple cell line models.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
The selective PI3Kα inhibitor ...... rom multiple cell line models.
@en
type
label
The selective PI3Kα inhibitor ...... rom multiple cell line models.
@en
prefLabel
The selective PI3Kα inhibitor ...... rom multiple cell line models.
@en
P2093
P2860
P50
P1433
P1476
The selective PI3Kα inhibitor ...... from multiple cell line models
@en
P2093
Ashley Grossman
Christian Fischer
Christoph J Auernhammer
Elke Tatjana Aristizabal Prada
GERMAN NET-Z study group
Helma Freitag
Jakob Rentsch
Jörg Schrader
Katharina Detjen
Patricia Grabowski
P2860
P304
P356
10.1371/JOURNAL.PONE.0182852
P407
P577
2017-08-11T00:00:00Z